Sterling Capital Management’s Nuvation Bio NUVB Stock Holding History

Sterling Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.1K	Sell	7,486 -5,443	-42%	-$30.3K	﹤0.01%	1816
2025 Q4	$116K	Sell	12,929 -2,973	-19%	-$18.4K	﹤0.01%	1475
2025 Q3	$58.8K	Buy	15,902 +9,650	+154%	+$26.3K	﹤0.01%	1707
2025 Q2	$12.2K	Buy	6,252 +3,124	+100%	+$6.51K	﹤0.01%	2004
2025 Q1	$5.5K	Sell	3,128 -2,679	-46%	-$6.1K	﹤0.01%	2120
2024 Q4	$15.4K	Buy	5,807 +5,180	+826%	+$13.3K	﹤0.01%	1960
2024 Q3	$1.44K	Buy	+627	New	+$1.91K	﹤0.01%	2357

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sterling Capital Management's NUVB Position: Q1 2026 in Review

Sterling Capital Management reduced its Nuvation Bio (NUVB) stake by 42% in Q1 2026, selling an estimated $30.3K and leaving 7,486 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Sterling Capital Management first reported a position in NUVB in Q3 2024 and has held it in 7 quarters since. The position peaked at $116K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Sterling Capital Management held 7,486 shares of Nuvation Bio worth $32.1K as of Q1 2026.
Sterling Capital Management sold 5,443 Nuvation Bio shares in Q1 2026, an estimated $30.3K.
Nuvation Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #1816 holding.
Sterling Capital Management first reported a position in Nuvation Bio in Q3 2024 and has held it in 7 quarters since.
Sterling Capital Management's Nuvation Bio position peaked at $116K in Q4 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.